Patents by Inventor Tony Tegeler

Tony Tegeler has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230213521
    Abstract: The application discloses in vitro methods for diagnosing lung cancer in a subject, wherein the method comprises detecting at least one biomarker selected from the group consisting of Rho GDP dissociation inhibitor beta (ARHGDIB), alpha-tubulin 4A (TUBA4A), glutathione S-transferase omega 1 (GSTO1), filamin A (FLNA), peroxiredoxin 6 (PRDX6) and cadherin 13 (CDH13) in a biological sample from the subject, and kits for measuring said at least one biomarker.
    Type: Application
    Filed: April 28, 2021
    Publication date: July 6, 2023
    Applicants: Luxembourg Institute of Health (LIH), Fred Hutchinson Cancer Center, The Translational Genomics Research Institute (TGEN)
    Inventors: Victoria EL KHOURY, Anna Elisabeth SCHRITZ, Yeoun Jin KIM, Guy BERCHEM, Amanda PAULOVICH, Jeffrey WHITEAKER, Konstantinos PETRITIS, Patrick PIRROTTE, Tony TEGELER
  • Publication number: 20160001198
    Abstract: Systems and methods for degassing liquids in nano-flow liquid applications (FIG. 3). In a chromatography embodiment, a system includes a buffer container, a degasser, a buffer pump, a nano-flow pump, and a separation column. The buffer pump is configured to move a buffer from the buffer container through the degasser and the nano-flow pump is configured to move the buffer from the buffer container or the degasser to the separation column.
    Type: Application
    Filed: February 25, 2014
    Publication date: January 7, 2016
    Applicant: The Translational Genomics Research Institute
    Inventors: Tony Tegeler, Konstantinos Petritis